Singular Genomics Systems (NASDAQ:OMIC) Trading Up 0.4% on Earnings Beat

Singular Genomics Systems, Inc. (NASDAQ:OMIC)’s share price was up 0.4% on Tuesday following a stronger than expected earnings report. The stock traded as high as $23.00 and last traded at $22.97. Approximately 6,086 shares traded hands during mid-day trading, a decline of 83% from the average daily volume of 34,845 shares. The stock had previously closed at $22.88.

The company reported ($6.72) earnings per share for the quarter, topping the consensus estimate of ($8.05) by $1.33. The company had revenue of $0.41 million for the quarter, compared to analyst estimates of $0.74 million. Singular Genomics Systems had a negative return on equity of 54.70% and a negative net margin of 3,237.89%.

Singular Genomics Systems Trading Up 1.0 %

The company has a market cap of $56.88 million, a price-to-earnings ratio of -0.65 and a beta of 1.51. The company’s 50 day moving average price is $15.32 and its 200 day moving average price is $11.33. The company has a debt-to-equity ratio of 0.05, a quick ratio of 8.04 and a current ratio of 8.77.

Singular Genomics Systems Company Profile

Singular Genomics Systems, Inc, a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables for applications comprising single cell gene expression and proteomics, in situ RNA sequencing, and spatial RNA and proteomics applications for tissue.